Sign in

CIK 0001534248 · Non-accelerated filer<br>Smaller reporting company

Chemomab Therapeutics Ltd.

Sign in to watch
Ticker
CMMB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
operating
EIN
813676773
Phone
972-77-331-0156
Business address
KIRYAT ATIDIM, BUILDING 7, TEL AVIV, Israel
Former names
Anchiano Therapeutics Ltd., BioCancell Ltd.
  1. 4 Open-market buy Chief Executive Officer bought 9,804 shares at an average $2.07 ($20,246)
  2. 6-K Event Report of Foreign Issuer
  3. 6-K Event Report of Foreign Issuer
  4. 6-K Event Report of Foreign Issuer
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 20-F Report Annual and Transition Report of Foreign Private Issuers
  14. 6-K Event Report of Foreign Issuer
  15. 6-K Event Report of Foreign Issuer
  16. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  17. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  18. 6-K Event Report of Foreign Issuer
  19. 6-K Event Report of Foreign Issuer
  20. 6-K Event Report of Foreign Issuer

Page 2 of 19 · 368 filings